TY  - JOUR
PY  - 2020//
TI  - Suicidality and cannabidiol: opportunities and challenges
JO  - Current neuropharmacology
A1  - Moazen-Zadeh, Ehsan
A1  - Galynker, Igor I.
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - Cannabidiol (CBD) is gaining considerable attention in the research community with promising results in a variety of neuropsychiatric conditions. In particular, there are replicated findings for the therapeutic effects of CBD on psychotic and anxiety symptoms as well as substance use disorders, all of which are highly prevalent in patients who present with suicidality. Meanwhile, there has been a lack of suicide research on cannabidiol. This perspective provides an overview of the available evidence, potential reasons behind the halt on suicide research on cannabidiol, and recommendations for future investigations.<p />  <p>Language: en</p>
LA  - en
SN  - 1570-159X
UR  - http://dx.doi.org/10.2174/1570159X18666201015160417
ID  - ref1
ER  -